Skip to main content
. 2021 Oct 28;8:719056. doi: 10.3389/fmolb.2021.719056

TABLE 4.

Association of promoter hypermethylation status of candidate genes with patient’s clinico-pathological features in EOC tissue samples. p-value: Pearson’s chi-square and Fisher’s exact tests. Abbreviation: Pos: biomarker panel positive for methylation; Neg: biomarker panel negative for methylation; NS: not significant. A positive biomarker panel is defined as when either or both gene promoter show methylation.

Tissue No. of patients HOXA9 a HIC1 a SOX1 RASSF1A SFRP1 SPARC DAPK1
Feature M U M U M U M U M U M U M U
Tumor 85 70 15 68 17 67 18 61 24 63 22 52 33 59 26
Healthy 35 5 30 8 27 7 28 10 25 10 25 11 24 10 25
P value <0.0001*** <0.0001*** < 0.0001*** < 0.0001*** < 0.0001*** 0.0046** <0.0001***
Histology
Serous 74 61 13 58 16 58 16 53 21 53 21 47 27 51 23
Mucinous 6 5 1 6 0 5 1 5 1 6 0 5 1 4 2
Benign 5 4 1 4 1 4 1 3 2 4 1 0 5 4 1
P value NS NS NS NS NS 0.0096** NS
FIGO stage
I/II 20 16 4 14 6 14 6 14 6 14 6 11 9 14 6
III/IV 65 54 11 54 11 53 12 47 18 49 16 41 24 45 20
P value NS NS NS NS NS NS NS
Age (Median =50)
≥ Median age 64 31 33 33 31 34 30 33 31 34 30 32 32 34 30
< Median age 56 44 12 43 13 41 15 38 18 39 17 31 25 35 21
P value 0.0007*** 0.0047** 0.0253* NS NS NS NS
Menopausal status
Pre 53 41 12 40 13 40 13 36 17 38 15 29 24 35 18
Post 67 34 33 36 31 35 32 35 32 35 32 34 33 34 33
P value 0.0042** 0.0216* 0.0132* NS 0.0385* NS NS
Tissue No. of patients HOXA9 + HIC1 a HOXA9 + SOX1 HIC1+ SOX1 HOXA9+ RASSF1A HIC1+ SFRP1 DAPK1+ SOX1
Feature Pos Neg Pos Neg Pos Neg Pos Neg Pos Neg Pos Neg
Tumor 85 75 10 73 12 71 14 65 20 67 18 62 23
Healthy 35 4 31 4 31 4 31 7 28 8 27 8 27
P value <0.00001*** < 0.0001*** < 0.0001*** < 0.0001*** < 0.0001*** < 0.0001***
Histology
Serous 74 65 9 61 13 60 14 57 17 57 17 53 21
Mucinous 6 6 0 5 1 6 0 5 1 6 0 4 2
Benign 5 4 1 4 1 4 1 2 3 4 1 4 1
P value NS NS NS NS NS NS
FIGO stage
I/II 20 16 4 15 5 14 6 13 7 14 6 14 6
III/IV 65 59 6 55 10 56 9 51 14 53 12 47 18
P value NS NS NS NS NS NS
Age (Median =50)
≥ Median age 64 33 31 31 33 31 33 31 33 32 32 30 34
< Median age 56 48 8 43 13 43 13 39 17 43 13 37 19
P value <0.0001*** 0.0024** 0.0024** 0.0258* 0.0027** 0.0432*
Menopausal status
Pre 53 45 8 40 13 41 12 37 16 40 13 37 16
Post 67 36 31 34 33 33 34 33 34 35 32 30 37
P value 0.0004*** 0.0079** 0.0023** 0.0265* 0.0132* 0.0093**
a

Promoter hypermethylation of DNA methylation markers-HOXA9 and HIC1 in singleplex and multiplex MethyLight assay analyzed in tissue samples has been previously published (Singh et al., 2020).